pocketful logo
SMS Pharmaceuticals Ltd logo

SMS Pharmaceuticals Ltd

NSE: SMSPHARMA BSE: 532815

₹385.20

(-1.08%)

Wed, 04 Mar 2026, 01:47 am

SMS Pharmaceuticals Enterprise Value (EV)

Particulars20052006200720082009201020112012201320142015201620172018201920202021202220232024
Price to earnings ratio011.026.1112.2767.8021.60124.567.5910.4912.1717.2725.4319.6413.167.1516.8412.76030.2527.27
Price to book ratio01.460.800.360.760.820.640.790.921.682.402.852.191.640.652.571.691.062.812.95
Price to sales ratio01.450.800.320.760.820.680.810.410.741.281.671.351.140.551.881.540.942.132.42
Price to cash flow ratio019.5849.853.918.3837.5315.0506.046.0213.3511.7528.3112.576.5812.4629.72291.1652.8329.22
Enterprise value02.58B2.34B1.94B3.2B3.62B3.4B2.79B3.69B5.93B8.99B8.62B7.57B6.56B3.73B12.67B10.11B7.36B17.52B21.55B
Enterprise value to EBITDA ratio05.055.460.7512.809.068.4906.457.0422.6111.888.227.504.9110.569.0913.7615.2515.65
Debt to equity ratio1.180.380.440.650.770.850.940.610.750.670.710.590.510.450.450.620.560.550.520.49
Return on equity %16.4120.5713.5731.133.870.5210.898.7514.7914.9110.3910.2613.219.4216.4814.13-1.521011.76

SMS Pharmaceuticals Ltd Enterprise Value

The SMS Pharmaceuticals Ltd Enterprise Value is a key financial metric used by investors to evaluate SMS Pharmaceuticals Ltd's valuation, profitability, and overall financial performance. Tracking the SMS Pharmaceuticals Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

SMS Pharmaceuticals Ltd (NSE: SMSPHARMA, BSE: 532815) is currently trading at ₹385.20, with a market capitalization of ₹35.98B. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the SMS Pharmaceuticals Ltd Enterprise Value is essential for fundamental analysis.

SMS Pharmaceuticals Ltd Enterprise Value Current Value

The current SMS Pharmaceuticals Ltd Enterprise Value stands at 21.55B.

The latest SMS Pharmaceuticals Ltd Enterprise Value has increased compared to the previous period, indicating rising valuation or improved investor sentiment.

SMS Pharmaceuticals Ltd Enterprise Value Historical Trend

The SMS Pharmaceuticals Ltd Enterprise Value has shown the following historical trend:

  • 2024: 21.55B
  • 2023: 17.52B
  • 2022: 7.36B
  • 2021: 10.11B
  • 2020: 12.67B

The recent rise in SMS Pharmaceuticals Ltd Enterprise Value suggests strengthening valuation trends and improving market sentiment.

What SMS Pharmaceuticals Ltd Enterprise Value Indicates for Investors

The SMS Pharmaceuticals Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of SMS Pharmaceuticals Ltd.

SMS Pharmaceuticals Ltd Enterprise Value Analysis Summary

The SMS Pharmaceuticals Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking SMS Pharmaceuticals Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of SMS Pharmaceuticals Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800